Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort

Addington, 1993, Assessing depression in schizophrenia : the calgary depression scale, Br. J. Psychiatr., 163, 39, 10.1192/S0007125000292581 Aroor, 2013, Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance, Metabolism, 62, 1543, 10.1016/j.metabol.2013.07.001 Bedrossian, 2016, Inflammation and elevation of interleukin-12p40 in patients with schizophrenia, Front. Mol. Neurosci., 9, 16, 10.3389/fnmol.2016.00016 Bernstein, 1994, Initial reliability and validity of a new retrospective measure of child abuse and neglect, Am. J. Psychiatr., 1132, 1132 Boiko, 2021, Cytokine level changes in schizophrenia patients with and without metabolic syndrome treated with atypical antipsychotics, Pharmaceuticals, 14, 446, 10.3390/ph14050446 Borovcanin, 2015, Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia, Psychoneuroendocrinology, 56, 143, 10.1016/j.psyneuen.2015.03.003 Bunea, 2011, Penalized least squares regression methods and applications to neuroimaging, Neuroimage, 55, 1519, 10.1016/j.neuroimage.2010.12.028 Buuren, 2010, Mice : Multivariate imputation by chained equations in R, J. Stat. Software, 1–68 Cardinali, 2017, Inflammaging, metabolic syndrome and melatonin : a call for treatment studies, Neuroendocrinology, 104, 382, 10.1159/000446543 Carney, 2016, Cardiometabolic risk factors in young people at ultra-high risk for psychosis : a systematic review and meta-analysis, Schizophr. Res., 170, 290, 10.1016/j.schres.2016.01.010 Chang, 2011, Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London, PLoS One, 6, 10.1371/journal.pone.0019590 Chen, 2016, Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia : relationships with clinical phenotypes and cognitive deficits, Psychol. Med., 46, 3219, 10.1017/S0033291716001902 Cordes, 2017, Prevalence of metabolic syndrome in female and male patients at risk of psychosis, Schizophr. Res., 181, 38, 10.1016/j.schres.2016.09.012 Correll, 2017, Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness : a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls, World Psychiatr., 16, 163, 10.1002/wps.20420 Debnath, 2017, Functional implications of the IL-23/IL-17 immune axis in schizophrenia, Mol. Neurobiol., 54, 8170, 10.1007/s12035-016-0309-1 2002 Fan, 2010, Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia, Schizophr. Res., 118, 211, 10.1016/j.schres.2010.02.1028 Felger, 2021, The intersection of inflammation and metabolism in neuropsychiatric disorders, Brain Behav. Immun., 93, 331, 10.1016/j.bbi.2020.12.025 First, 1997 Franceschi, 2018, Inflammaging : a new immune–metabolic viewpoint for age-related diseases, Nat. Rev. Endocrinol., 14, 576, 10.1038/s41574-018-0059-4 Friedman, 2010, Regularization paths for generalized linear models via coordinate descent, J. Stat. Software, 33, 1 Frydecka, 2018, Profiling inflammatory signatures of schizophrenia : a cross-sectional and meta-analysis study, Brain Behav. Immun., 71, 28, 10.1016/j.bbi.2018.05.002 Glass, 2012, Inflammation and lipid signaling in the etiology of insulin resistance, Cell Metabol., 15, 635, 10.1016/j.cmet.2012.04.001 Godin, 2015, Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia : results from the FACE-SZ cohort, Schizophr. Res., 168, 388, 10.1016/j.schres.2015.07.047 Godin, 2018, Metabolic syndrome and illness severity predict relapse at 1-year follow-up in schizophrenia : the FACE-SZ cohort, J. Clin. Psychiatr., 79, 10.4088/JCP.17m12007 Goldsmith, 2020, Inflammation and negative symptoms of schizophrenia : implications for reward processing and motivational deficits, Front. Psychiatr., 11, 10.3389/fpsyt.2020.00046 Graham, 2007, How many imputations are really needed? Some practical clarifications of multiple imputation theory, Prev. Sci., 8, 206, 10.1007/s11121-007-0070-9 Gregor, 2011, Inflammatory mechanisms in obesity, Annu. Rev. Immunol., 29, 415, 10.1146/annurev-immunol-031210-101322 Henderson, 2015, Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses, Lancet Psychiatr., 2, 452, 10.1016/S2215-0366(15)00115-7 Hiles, 2016, Bidirectional prospective associations of metabolic syndrome components with depression, anxiety, and antidepressant use, Depress. Anxiety, 33, 754, 10.1002/da.22512 Hotamisligil, 2010, Endoplasmic reticulum stress and the inflammatory basis of metabolic disease, Cell, 140, 900, 10.1016/j.cell.2010.02.034 Howes, 2017, Treatment-resistant schizophrenia : treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology, Am. J. Psychiatr., 174, 216, 10.1176/appi.ajp.2016.16050503 Kay, 1987, The positive and negative syndrome scale (PANSS) for schizophrenia, Schizophr. Bull., 13, 261, 10.1093/schbul/13.2.261 Kelly, 2019, Total and differential white blood cell counts, inflammatory markers, adipokines, and incident metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study, Schizophr. Res., 209, 193, 10.1016/j.schres.2019.04.021 Khandaker, 2015, Inflammation and immunity in schizophrenia : implications for pathophysiology and treatment, Lancet Psychiatr., 2, 258, 10.1016/S2215-0366(14)00122-9 Kim, 2012, Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa, Clin. Immunol., 144, 190, 10.1016/j.clim.2012.06.009 Kowal, 2020, Psychotic, mood, and anxiety disorders and venous thromboembolism : a systematic review and meta-analysis, Psychosom. Med., 82, 838, 10.1097/PSY.0000000000000863 Kozlowska, 2018, Human cathelicidin LL-37–Does it influence the homeostatic imbalance in mental disorders?, J. Biosci., 43, 321, 10.1007/s12038-018-9751-8 Kuhn, 2008, Building predictive models in R using the caret package, J. Stat. Software, 28 Lamers, 2018, Metabolic and inflammatory markers : associations with individual depressive symptoms, Psychol. Med., 48, 1102, 10.1017/S0033291717002483 Lamers, 2020, Depression profilers and immuno-metabolic dysregulation : longitudinal results from the NESDA study, Brain Behav. Immun., 88, 174, 10.1016/j.bbi.2020.04.002 Lasić, 2014, Metabolic syndrome and inflammation markers in patients with schizophrenia and recurrent depressive disorder, Psychiatr. Danub., 26 Laursen, 2012, Life expectancy and cardiovascular mortality in persons with schizophrenia, Curr. Opin. Psychiatr., 25, 83, 10.1097/YCO.0b013e32835035ca Lee, 2019, A novel biomarker of cardiometabolic pathology in schizophrenia?, J. Psychiatr. Res., 117, 31, 10.1016/j.jpsychires.2019.06.011 Lee, 2015, IL-7 receptor deletion ameliorates diet-induced obesity and insulin resistance in mice, Diabetologia, 58, 2361, 10.1007/s00125-015-3684-7 Liemburg, 2018, Relation of inflammatory markers with symptoms of psychotic disorders : a large cohort study, Prog. Neuro Psychopharmacol. Biol. Psychiatr., 86, 89, 10.1016/j.pnpbp.2018.04.006 Lv, 2015, Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics : correlation with psychopathology and cognition, Psychopharmacology, 232, 165, 10.1007/s00213-014-3650-y Maruotti, 2015, Metabolic syndrome and chronic arthritis : effects of anti-TNF-α therapy, Clin. Exp. Med., 15, 433, 10.1007/s10238-014-0323-4 McCracken, 2018, Pathophysiology of the metabolic syndrome, Clin. Dermatol., 36, 14, 10.1016/j.clindermatol.2017.09.004 McEvoy, 2005, Prevalence of the metabolic syndrome in patients with schizophrenia : baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III, Schizophr. Res., 80, 19, 10.1016/j.schres.2005.07.014 Medeiros-Ferreira, 2013, Metabolic syndrome and health-related quality of life in patients with schizophrenia, Actas Esp. Psiquiatr., 41, 17 Miller, 2011, Meta-analysis of cytokine alterations in schizophrenia : clinical status and antipsychotic effects, Biol. Psychiatr., 70, 663, 10.1016/j.biopsych.2011.04.013 Miller, 2013, Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses, Brain Behav. Immun., 31, 82, 10.1016/j.bbi.2012.08.016 Minns, 2021, The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation, Nat. Commun., 12, 1, 10.1038/s41467-021-21533-5 Mitchell, 2013, Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders—a systematic review and meta-analysis, Schizophr. Bull., 39, 306, 10.1093/schbul/sbr148 Mondelli, 2015, Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis, Schizophr. Bull., 41, 1162, 10.1093/schbul/sbv028 Morris, 2016, The many neuroprogressive actions of tryptophan catabolites (TRYCATs) that may be associated with the pathophysiology of neuro-immune disorders, Curr. Pharmaceut. Des., 22, 963, 10.2174/1381612822666151215102420 Nikolajuk, 2015, Relationship between serum IL-12 and p40 subunit concentrations and lipid parameters in overweight and obese women, Metab. Syndr. Relat. Disord., 13, 336, 10.1089/met.2014.0164 Penninx, 2018, Metabolic syndrome in psychiatric patients : overview, mechanisms, and implications, Dialogues Clin. Neurosci., 20, 63, 10.31887/DCNS.2018.20.1/bpenninx Pilatz, 2017, Metabolic syndrome and the seminal cytokine network in morbidly obese males, Andrology, 5, 23, 10.1111/andr.12296 Pillinger, 2017, Impaired glucose homeostasis in first-episode schizophrenia : a systematic review and meta-analysis, JAMA Psychiatr., 74, 261, 10.1001/jamapsychiatry.2016.3803 Pillinger, 2017, Cholesterol and triglyceride levels in first-episode psychosis : systematic review and meta-analysis, Br. J. Psychiatr., 211, 339, 10.1192/bjp.bp.117.200907 Pillinger, 2020, Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology : a systematic review and network meta-analysis, Lancet Psychiatr., 7, 64, 10.1016/S2215-0366(19)30416-X Révész, 2018, Associations between cellular aging markers and metabolic syndrome : findings from the CARDIA study, J. Clin. Endocrinol. Metabol., 103, 148, 10.1210/jc.2017-01625 Rojo, 2015, Metabolic syndrome and obesity among users of second generation antipsychotics : a global challenge for modern psychopharmacology, Pharmacol. Res., 101, 74, 10.1016/j.phrs.2015.07.022 Ryan, 2003, Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia, Am. J. Psychiatr., 160, 284, 10.1176/appi.ajp.160.2.284 Saidijam, 2014, Expression of interleukins 7 & 8 in peripheral blood mononuclear cells from patients with metabolic syndrome : a preliminary study, Indian J. Med. Res., 140, 238 Saxena, 2018, A network biology approach for assessing the role of pathologic adipose tissues in insulin resistance using meta-analysis of microarray datasets, Curr. Genom., 19, 630, 10.2174/1389202919666180726125645 Schürhoff, 2015, FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) collaborators, Eur Psychiatry, 30, 728, 10.1016/j.eurpsy.2015.05.004 Slagter, 2017, Sex, BMI and age differences in metabolic syndrome : the Dutch Lifelines Cohort Study, Endocrine Connect., 6, 278, 10.1530/EC-17-0011 Spelman, 2007, Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia, Diabet. Med., 24, 481, 10.1111/j.1464-5491.2007.02092.x Srikanthan, 2016, Systematic review of metabolic syndrome biomarkers : a panel for early detection, management, and risk stratification in the West Virginian population, Int. J. Med. Sci., 13, 25, 10.7150/ijms.13800 Startup, 2002, The concurrent validity of the global assessment of functioning (GAF), Br. J. Clin. Psychol., 41, 417, 10.1348/014466502760387533 Strand, 2021, Relationships between plasma levels and six proinflammatory interleukins and body composition using a new magnetic resonance imaging voxel-based technique, Cytokine X, 3, 100050, 10.1016/j.cytox.2020.100050 Sun, 2014, Alcohol consumption and risk of metabolic syndrome : a meta-analysis of prospective studies, Clin. Nutr., 33, 596, 10.1016/j.clnu.2013.10.003 Suttajit, 2013, Prevalence of metabolic syndrome and its association with depression in patients with schizophrenia, Neuropsychiatric Dis. Treat., 9, 941, 10.2147/NDT.S47450 Tahmasebinia, 2017, The role of Th17 cells in auto-inflammatory neurological disorders, Prog. Neuro Psychopharmacol. Biol. Psychiatr., 79, 408, 10.1016/j.pnpbp.2017.07.023 Tamouza, 2020, The HLA 8.1 ancestral haplotype in schizophrenia : dual implication in neuro-synaptic pruning and autoimmunity?, Acta Psychiatr. Scand., 141, 169, 10.1111/acps.13125 Tan, 2001, IL-7 is critical for homeostatic proliferation and survival of naive T cells, Proc. Natl. Acad. Sci. Unit. States Am., 98, 8732, 10.1073/pnas.161126098 Thakore, 2002, Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia, Int. J. Obes., 26, 137, 10.1038/sj.ijo.0801840 Trayhurn, 2004, Adipokines : inflammation and the pleiotropic role of white adipose tissue, Br. J. Nutr., 92, 347, 10.1079/BJN20041213 Vancampfort, 2015, Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder : a systematic review and meta-analysis, World Psychiatr., 14, 339, 10.1002/wps.20252 Vernay, 2013, Metabolic syndrome and socioeconomic status in France : the French Nutrition and Health Survey (ENNS, 2006–2007), Int. J. Publ. Health, 58, 855, 10.1007/s00038-013-0501-2 Young, 1978, A rating scale for mania : reliability, validity and sensitivity, Br. J. Psychiatr., 133, 429, 10.1192/bjp.133.5.429 Zak, 2007, Circulating interleukin-16 in blood of patients with metabolic syndrome and type 2 diabetes mellitus, Likars'Ka Sprava, 5–6, 46